First US Women Successfully Received Breast Augmentation with Newly Approved Motiva Implants 

The first patients in the United States successfully received breast augmentations with Motive Implants, a week after receiving approval from the US Food and Drug Administration, Establishment Labs Holding Inc. announced in a press release last month. 

“With the FDA approval last week, we are experiencing high demand for Motiva Implants — both from surgeons and patients,” said Juan José Chacón-Quirós, Founder and Chief Executive Officer of Establishment Labs. “The FDA approval came as we were attending the annual conference of the American Society of Plastic Surgeons. The response was overwhelming, and our team has already talked to more than 400 plastic surgeons post announcement. Since approval, we have already doubled our team to 25 sales reps across the United States, and our story of real innovation, backed by science and data, is resonating strongly. Everything we are seeing suggests that we can be the implant of choice in the United States.”

The plastic surgeons who performed the first surgeries following the FDA approval were Kentucky-based board-certified plastic surgeon Dr. M. Bradley Calobrace and New Jersey-based board-certified plastic surgeon Dr. Caroline A. Glicksman. 

“I have many patients that have been waiting a long time for Motiva approval, in some cases, for years,” said Dr. Calobrace. “I was delighted to perform one of the first Motiva breast augmentations in the United States. The innovation in these devices not only enhances aesthetics outcomes, but also significantly lowers the rates of the complications we see with other devices. Motiva implants are a game changer.”

Motiva Implants feature the SmoothSilk surface, which is designed for enhanced biocompatibility and scientifically shown to promote low inflammation, according to a press release. 

The 6th generation implants are offered in two distinct implant styles. Motiva SmoothSilk Ergonomix is the first breast implant in the world that embodies the science of ergonomics and is designed to react, feel, and move like natural breast tissue. The implants are unique as their shape can adapt as the body changes position, maintaining a round shape when lying down and a teardrop shape when standing up.

Motiva SmoothSilk Round implants provide increased upper breast fullness and softness while keeping a round full form regardless of position. 

“The plastic surgery community has waited more than a decade to offer breast augmentation patients in the United States something truly new,” said Dr. Glicksman, Medical Director of the Motiva U.S. IDE Study and a clinical trial investigator. “Now, we can confidently offer our patients implants that have consistently shown low complication rates and high patient satisfaction.”

For more information on Motiva Breast Implants, click here.